日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Online Optimizing Control and Dynamic Operation and Design Optimization of a Batch Electrodialysis Process for Sulfuric Acid Recovery

在线优化控制、动态运行及设计优化：用于硫酸回收的间歇式电渗析工艺

期刊:Industrial & Engineering Chemistry Research
影响因子:3.9
doi:10.1021/acs.iecr.5c02832
Latinis, Athanasios; Papadopoulos, Athanasios I; Seferlis, Panagiotis
发表日期：2026
文献求助 收藏

Is conservative management safe for mesenteric venous ischemia? Two case reports

保守治疗肠系膜静脉缺血安全吗？两例病例报告

期刊:Journal of Surgical Case Reports
影响因子:0.5
doi:10.1093/jscr/rjaf318
Santos, Bruno Matos; Latinis, Florence; Podetta, Michele; Scarpa, Cosimo Riccardo
发表日期：2025
文献求助 收藏

Incidental pneumatosis intestinalis in a patient with chronic kidney disease: a case report

慢性肾脏病患者并发肠壁积气：病例报告

期刊:Journal of Surgical Case Reports
影响因子:0.5
doi:10.1093/jscr/rjaf168
Dirhoussi, Lina Berrada; Latinis, Florence
发表日期：2025
文献求助 收藏

Blockade of interferon-γ normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus

阻断干扰素-γ可使系统性红斑狼疮患者的干扰素调节基因表达和血清CXCL10水平恢复正常

期刊:Arthritis & Rheumatology
影响因子:11.4
doi:10.1002/art.39248
Andrew A Welcher ,Michael Boedigheimer ,Alan J Kivitz ,Zahir Amoura ,Jill Buyon ,Alla Rudinskaya ,Kevin Latinis ,Kit Chiu ,Kelly S Oliner ,Michael A Damore ,Gregory E Arnold ,Winnie Sohn ,Narendra Chirmule ,Lovely Goyal ,Christopher Banfield ,James B Chung
免疫/内分泌
红斑狼疮
CXCL10
CXCL1
发表日期：2015
文献求助 收藏

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))

利妥昔单抗不同剂量和再治疗的疗效和安全性：一项针对生物学初治、活动性类风湿关节炎且对甲氨蝶呤反应不足患者的随机、安慰剂对照试验（评估利妥昔单抗对甲氨蝶呤反应不足患者的疗效研究 (SERENE)）

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard.2009.119933
Emery, P; Deodhar, A; Rigby, W F; Isaacs, J D; Combe, B; Racewicz, A J; Latinis, K; Abud-Mendoza, C; Szczepanski, L J; Roschmann, R A; Chen, A; Armstrong, G K; Douglass, W; Tyrrell, H
关节炎
发表日期：2010
文献求助 收藏

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial

利妥昔单抗治疗中重度活动性系统性红斑狼疮的疗效和安全性：一项随机、双盲、II/III期系统性红斑狼疮利妥昔单抗疗效评估试验

期刊:Arthritis and Rheumatism
影响因子:
doi:10.1002/art.27233
Merrill, Joan T; Neuwelt, C Michael; Wallace, Daniel J; Shanahan, Joseph C; Latinis, Kevin M; Oates, James C; Utset, Tammy O; Gordon, Caroline; Isenberg, David A; Hsieh, Hsin-Ju; Zhang, David; Brunetta, Paul G
红斑狼疮
免疫/内分泌
发表日期：2010
文献求助 收藏

Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity

DAP10 和 ITAM 介导的 NK 细胞毒性对 Vav 蛋白的不同需求

期刊:Journal of Experimental Medicine
影响因子:10.6
doi:10.1084/jem.20031847
Cella, Marina; Fujikawa, Keiko; Tassi, Ilaria; Kim, Sunjin; Latinis, Kevin; Nishi, Shinzo; Yokoyama, Wayne; Colonna, Marco; Swat, Wojciech
细胞生物学
NK 细胞
毒理研究
发表日期：2004
文献求助 收藏